1. Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer


    Liang Zeng et al, 2020, OncoTargets and Therapy CrossRef
  2. Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer
    Yan Xiang et al, 2022, Current Oncology CrossRef
  3. Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis
    Zaixiang Fu et al, 2022, Frontiers in Oncology CrossRef